DARE (Dare Bioscience) Short Interest


DARE Dare Bioscience Inc DARE
23 GF Score
Price $2.00
! 4 Warning Signs
View Full Analysis

What is Dare Bioscience Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

DARE vs TVGN, LITS, BOLD: Short Interest Comparison

For the Biotechnology subindustry, Dare Bioscience's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dare Bioscience Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dare Bioscience's Short Interest distribution charts can be found below:

* The bar in red indicates where Dare Bioscience's Short Interest falls into.


DARE
23GF Score
Dare Bioscience Inc DARE
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dare Bioscience Business Description

Address 3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
23GF Score

Get the complete analysis for DARE

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.00
Price